Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer
https://www.powershow.com/view4/7ca781-MWNkZ/Phase_II_trial_of_the_oral_PARP_inhibitor_olaparib_AZD2281_in_BRCA-deficient_advanced_ovarian_cancer_powerpoint_ppt_presentation
Icons create by Freepik from www.flaticon.com/